Thursday 18 October 2018
Contact US    |    Archive
Channel News Asia
30 days ago

Viking shares soar as liver disease drug succeeds in mid-stage study

REUTERS: Viking Therapeutics Inc s shares more than doubled on Tuesday after its experimental liver disease treatment met the goals of a mid-stage trial by lowering cholesterol and liver fat levels in patients. The study tested Viking s VK2809 against a placebo in patients with non-alcoholic fatty ...

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Viking

 | 

shares

 | 

soar

 | 

liver

 | 

disease

 | 

drug

 | 

succeeds

 | 

mid

 | 

stage

 | 

study

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)